Tuesday, December 16, 2008

Going to the Dogs

It always seems that dogs have it better, at least in the Cushing's world.  Easier and faster diagnosis; less severe treatment options.  So today, another drug for dogs has been FDA approved.  It would be nice if the FDA approved all these meds - or better ones! - for people.  <sigh>


VETORYL(R) (Trilostane) Receives FDA Approval
Posted 15 December 2008 @ 05:43 pm EST

OVERLAND PARK, Kan., Dec. 15 /PRNewswire/ -- Dechra Veterinary ProductsLLC today announces that the company has received FDA approval to market VETORYL(R) Capsules.

VETORYL Capsules contain the drug trilostane, which has been demonstrated to be effective in the treatment of Cushing's syndrome in dogs. VETORYL will be indicated for use in pituitary-dependent hyperadrenocorticism, which comprises the majority of cases of Cushing's syndrome in dogs. Additionally,VETORYL has received designation status as a Minor Use Drug for treatment of hyperadrenocorticism caused by adrenal tumors -- the first drug to receive an approval for this indication and the first drug to receive a Minor Use designation in dogs.

Mike Eldred, President of U.S. Operations, says, "We are very excited to have approval to market this novel product in the U.S. Following its launch in January, veterinarians will be able to source the product through our network of distribution partners."